The secretome of liver X receptor agonist‐treated early outgrowth cells decreases atherosclerosis in Ldlr−/− mice

The secretome of liver X receptor agonist‐treated early outgrowth cells decreases atherosclerosis in Ldlr−/− mice

Abstract Endothelial progenitor cells (EPCs) promote the maintenance of the endothelium by secreting vasoreparative factors. A population of EPCs known as early outgrowth cells (EOCs) is being investigated as novel cell‐based therapies for the treatment of cardiovascular disease. We previously demon...

Full description

Bibliographic Details
Main Authors: Adil Rasheed, Sarah A. Shawky, Ricky Tsai, Richard G. Jung, Trevor Simard, Michael F. Saikali, Benjamin Hibbert, Katey J. Rayner, Carolyn L. Cummins
Format: Article
Language:English
Published: Oxford University Press 2021-03-01
Series:Stem Cells Translational Medicine
Subjects:
atherosclerosis
autologous cell therapy
early outgrowth cells
liver X receptor
secreted factors
Online Access:https://doi.org/10.1002/sctm.19-0390

Internet

https://doi.org/10.1002/sctm.19-0390

Similar Items